Time Left - 15:00 mins
RBI Asst./Sbi Clerk Main Exam 2020: Quiz 47 ( 1.05.2020)
Attempt now to get your rank among 1069 students!
Question 1
Directions: Read the following passage carefully and the questions that follow. Certain words/ phrases are given in bold to help you locate them while answering some of the questions
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Why do private companies indulge in emotional marketing?
Question 2
Directions: Read the following passage carefully and the questions that follow. Certain words/ phrases are given in bold to help you locate them while answering some of the questions
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
It can be inferred from the passage that:
Question 3
Directions: Read the following passage carefully and the questions that follow. Certain words/ phrases are given in bold to help you locate them while answering some of the questions
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Which of the following has not been cited as a reason to promote the use of cord blood?
Question 4
Directions: Read the following passage carefully and the questions that follow. Certain words/ phrases are given in bold to help you locate them while answering some of the questions
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
How does the author want to set up cord blood banks?
Question 5
Directions: Read the following passage carefully and the questions that follow. Certain words/ phrases are given in bold to help you locate them while answering some of the questions
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
What is meant by the statement 'Cord blood banks can draw on altruism to get voluntary donations'?
Question 6
Direction: In this question, a number series is given. Only one number is wrong which doesn’t fit in the series. Find out the wrong number.
2, 7, 27, 107, 427, 1708, 6827
Question 7
Direction:Find the wrong term in the given series:
415, 506, 604, 709, 820, 940
Question 8
Direction: In the following number series, only one number is incorrect. Find out the incorrect number.
82, 65, 84, 61, 88, 59
Question 9
Direction: In these question, a number series is given. Only one number is wrong which doesn’t fit in the series. Find out the wrong number.
15, 19, 81, 119, 631, 731
Question 10
Direction:Find the wrong term in the given series:
7.2, 8.7, 10.8, 14.1, 19.8, 30.2, 50.4
Question 11
Direction: Study the following information and answer the question given below it.
Seven representatives of a company viz. Samir, Nita, Richa, Shweta, Gifty, Paul and Mohit travelled to three different countries, ie, South Africa, Australia and France. Each of them travelled on different days of the week (no two persons travelled on the same day), starting on Monday and ending on Sunday. Minimum two people travelled to each country and South Africa is the only country to which three people travelled. Samir travelled to South Africa on Monday. Paul travelled to Australia but neither on Tuesday nor on Saturday. Mohit travelled on Sunday but not to France. The one who travelled to Australia travelled on Tuesday and the one who travelled to France travelled on Saturday. Gifty travelled on Wednesday. Richa travelled to South Africa but not on Thursday. Nita did not travel to France.
If everyone’s trip is postponed by one day, who will be travelling on Wednesday ?
Question 12
Direction: Study the following information and answer the question given below it.
Seven representatives of a company viz. Samir, Nita, Richa, Shweta, Gifty, Paul and Mohit travelled to three different countries, ie, South Africa, Australia and France. Each of them travelled on different days of the week (no two persons travelled on the same day), starting on Monday and ending on Sunday. Minimum two people travelled to each country and South Africa is the only country to which three people travelled. Samir travelled to South Africa on Monday. Paul travelled to Australia but neither on Tuesday nor on Saturday. Mohit travelled on Sunday but not to France. The one who travelled to Australia travelled on Tuesday and the one who travelled to France travelled on Saturday. Gifty travelled on Wednesday. Richa travelled to South Africa but not on Thursday. Nita did not travel to France.
Who amongst the seven representatives travelled on Saturday ?
Question 13
Direction: Study the following information and answer the question given below it.
Seven representatives of a company viz. Samir, Nita, Richa, Shweta, Gifty, Paul and Mohit travelled to three different countries, ie, South Africa, Australia and France. Each of them travelled on different days of the week (no two persons travelled on the same day), starting on Monday and ending on Sunday. Minimum two people travelled to each country and South Africa is the only country to which three people travelled. Samir travelled to South Africa on Monday. Paul travelled to Australia but neither on Tuesday nor on Saturday. Mohit travelled on Sunday but not to France. The one who travelled to Australia travelled on Tuesday and the one who travelled to France travelled on Saturday. Gifty travelled on Wednesday. Richa travelled to South Africa but not on Thursday. Nita did not travel to France.
Which one of the following combinations is true according to the given information ?
Question 14
Direction: Study the following information and answer the question given below it.
Seven representatives of a company viz. Samir, Nita, Richa, Shweta, Gifty, Paul and Mohit travelled to three different countries, ie, South Africa, Australia and France. Each of them travelled on different days of the week (no two persons travelled on the same day), starting on Monday and ending on Sunday. Minimum two people travelled to each country and South Africa is the only country to which three people travelled. Samir travelled to South Africa on Monday. Paul travelled to Australia but neither on Tuesday nor on Saturday. Mohit travelled on Sunday but not to France. The one who travelled to Australia travelled on Tuesday and the one who travelled to France travelled on Saturday. Gifty travelled on Wednesday. Richa travelled to South Africa but not on Thursday. Nita did not travel to France.
To which country and on which day did Nita travel?
Question 15
Direction: Study the following information and answer the question given below it.
Seven representatives of a company viz. Samir, Nita, Richa, Shweta, Gifty, Paul and Mohit travelled to three different countries, ie, South Africa, Australia and France. Each of them travelled on different days of the week (no two persons travelled on the same day), starting on Monday and ending on Sunday. Minimum two people travelled to each country and South Africa is the only country to which three people travelled. Samir travelled to South Africa on Monday. Paul travelled to Australia but neither on Tuesday nor on Saturday. Mohit travelled on Sunday but not to France. The one who travelled to Australia travelled on Tuesday and the one who travelled to France travelled on Saturday. Gifty travelled on Wednesday. Richa travelled to South Africa but not on Thursday. Nita did not travel to France.
Who was the last one to travel ?
Question 16
What amount of liquidity facility has been announced by the Reserve Bank of India for mutual funds?
Question 17
According to a CRISIL Research report which state is at first position in terms of total installed renewable capacity in FY20?
Question 18
Who has been appointed as the Chairperson of the Public Enterprises Selection Board (PESB) for a period of 3 years?
Question 19
Which of the following becomes the 1st non-bank company to receive Reserve Bank of India (RBI) nod to enter into co-branding arrangements for prepaid Instruments?
Question 20
Every year 30th April is celebrated as which of the following days?
- 1069 attempts
- 3 upvotes
- 12 comments
Jun 21PO, Clerk, SO, Insurance
